STADOL Drug Patent Profile
✉ Email this page to a colleague
When do Stadol patents expire, and when can generic versions of Stadol launch?
Stadol is a drug marketed by Apothecon and Bristol Myers Squibb and is included in two NDAs.
The generic ingredient in STADOL is butorphanol tartrate. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the butorphanol tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Stadol
A generic version of STADOL was approved as butorphanol tartrate by HIKMA on August 12th, 1998.
Summary for STADOL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 16 |
Patent Applications: | 1,586 |
Formulation / Manufacturing: | see details |
DailyMed Link: | STADOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for STADOL
US Patents and Regulatory Information for STADOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | STADOL | butorphanol tartrate | INJECTABLE;INJECTION | 017857-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | STADOL PRESERVATIVE FREE | butorphanol tartrate | INJECTABLE;INJECTION | 017857-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | STADOL | butorphanol tartrate | SPRAY, METERED;NASAL | 019890-001 | Dec 12, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | STADOL PRESERVATIVE FREE | butorphanol tartrate | INJECTABLE;INJECTION | 017857-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for STADOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | STADOL | butorphanol tartrate | SPRAY, METERED;NASAL | 019890-001 | Dec 12, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for STADOL
See the table below for patents covering STADOL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Malaysia | 7900027 | 3-SUBSTITUTED-MORPHINAN DERIVATIVES | ⤷ Try a Trial |
Ireland | 36688 | 3-SUBSTITUTED-MORPHINAN DERIVATIVES | ⤷ Try a Trial |
Japan | S5310596 | ⤷ Try a Trial | |
Hong Kong | 2679 | 3-SUBSTITUTED-MORPHINAN DERIVATIVES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |